BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 34320398)

  • 21. [Correlation analysis between 18F-FDG uptake features and the prognosis in patients with pathologic stage Ⅰ lung adenocarcinoma].
    Liu Y; Wu N; Bi GC; Zhang DS; Zheng R; Liang Y; Zhang WJ; Li XM; Fang Y
    Zhonghua Zhong Liu Za Zhi; 2016 Apr; 38(4):263-9. PubMed ID: 27087372
    [TBL] [Abstract][Full Text] [Related]  

  • 22. F-18 FDG uptake on positron emission tomography as a predictor for lymphovascular invasion in patients with lung adenocarcinoma.
    Noda Y; Goshima S; Kanematsu M; Watanabe H; Kawada H; Kawai N; Ono H; Bae KT
    Ann Nucl Med; 2016 Jan; 30(1):11-7. PubMed ID: 26337532
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preoperative Standardized Uptake Value of Metastatic Lymph Nodes Measured by 18F-FDG PET/CT Improves the Prediction of Prognosis in Gastric Cancer.
    Song BI; Kim HW; Won KS; Ryu SW; Sohn SS; Kang YN
    Medicine (Baltimore); 2015 Jul; 94(26):e1037. PubMed ID: 26131811
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pretreatment [18F]-fluoro-2-deoxy-glucose positron emission tomography maximum standardized uptake value as predictor of distant metastasis in early-stage non-small cell lung cancer treated with definitive radiation therapy: rethinking the role of positron emission tomography in personalizing treatment based on risk status.
    Nair VJ; MacRae R; Sirisegaram A; Pantarotto JR
    Int J Radiat Oncol Biol Phys; 2014 Feb; 88(2):312-8. PubMed ID: 24411602
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Semiquantitative parameters of
    Liao XH; Wang RF; Liu M; Chen XQ; Xiong Y; Nong L; Yin L; Zhang BY; DU YJ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Oct; 53(2):246-254. PubMed ID: 33879893
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic thresholds of fluorine-18 fluorodeoxyglucose-positron emission tomography mean and maximum standardized uptake values for survival and nodal involvement in lung neuroendocrine neoplasms.
    Soldath P; Binderup T; Kjaer A; Knigge U; Langer SW; Petersen RH
    Eur J Cardiothorac Surg; 2024 Feb; 65(2):. PubMed ID: 38305412
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The maximum standardized uptake value of fluorodeoxyglucose positron emission tomography of the primary tumour is a good predictor of pathological nodal involvement in clinical N0 non-small-cell lung cancer.
    Miyasaka Y; Suzuki K; Takamochi K; Matsunaga T; Oh S
    Eur J Cardiothorac Surg; 2013 Jul; 44(1):83-7. PubMed ID: 23233074
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preoperative prediction of the pathological stage of advanced gastric cancer by
    Yamada K; Urakawa N; Kanaji S; Hasegawa H; Yamamoto M; Yamashita K; Matsuda T; Oshikiri T; Suzuki S; Kakeji Y
    Sci Rep; 2022 Jul; 12(1):11370. PubMed ID: 35790785
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic value of preoperative positron emission tomography in resected stage I non-small cell lung cancer.
    Goodgame B; Pillot GA; Yang Z; Shriki J; Meyers BF; Zoole J; Gao F; Dehdashti F; Patterson A; Siegel BA; Govindan R
    J Thorac Oncol; 2008 Feb; 3(2):130-4. PubMed ID: 18303432
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical Value of
    Chen Z; Jiang S; Li Z; Rao L; Zhang X
    Acad Radiol; 2020 Dec; 27(12):1691-1699. PubMed ID: 32063495
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictive value of primary fluorine-18 fluorodeoxyglucose standard uptake value for a better choice of systematic nodal dissection or sampling in clinical stage ia non--small-cell lung cancer.
    Li X; Zhang H; Xing L; Xu X; Xie P; Ma H; Zhang L; Chen M; Sun X; Xu W; Chen L; Yu J
    Clin Lung Cancer; 2013 Sep; 14(5):568-73. PubMed ID: 23835164
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Correlation between TNM staging of primary cholangiocarcinoma and the maximum standard uptake value of (18)F-2-deoxy-D-glucose positron emission tomography with computerized tomography].
    Wang ZF; Lan XL; Xiao YR; Liu JP; Ji JS
    Zhonghua Yi Xue Za Zhi; 2017 Oct; 97(39):3104-3107. PubMed ID: 29081157
    [No Abstract]   [Full Text] [Related]  

  • 33. Prediction of true-negative lymph node metastasis in clinical IA non-small cell lung cancer by measuring standardized uptake values on positron emission tomography.
    Takenaka T; Yano T; Morodomi Y; Ito K; Miura N; Kawano D; Shoji F; Baba S; Abe K; Honda H; Maehara Y
    Surg Today; 2012 Oct; 42(10):934-9. PubMed ID: 22864936
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Close association of IASLC/ATS/ERS lung adenocarcinoma subtypes with glucose-uptake in positron emission tomography.
    Nakamura H; Saji H; Shinmyo T; Tagaya R; Kurimoto N; Koizumi H; Takagi M
    Lung Cancer; 2015 Jan; 87(1):28-33. PubMed ID: 25481488
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic value of 18F-FDG uptake on positron emission tomography in patients with pathologic stage I non-small cell lung cancer.
    Um SW; Kim H; Koh WJ; Suh GY; Chung MP; Kwon OJ; Choi JY; Han J; Lee KS; Kim J
    J Thorac Oncol; 2009 Nov; 4(11):1331-6. PubMed ID: 19701106
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of maximum standardized uptake value on fluorodeoxyglucose positron-emission tomography in predicting lymph node involvement in patients with primary non-small cell lung cancer.
    Muto J; Hida Y; Kaga K; Ohtaka K; Okamoto S; Tamaki N; Nakada-Kubota R; Hirano S; Matsui Y
    Anticancer Res; 2014 Feb; 34(2):805-10. PubMed ID: 24511016
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The value of preoperative positron emission tomography/computed tomography in differentiating the invasive degree of hypometabolic lung adenocarcinoma.
    Su Y; Zhou H; Huang W; Li L; Wang J
    BMC Med Imaging; 2023 Feb; 23(1):31. PubMed ID: 36765284
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 18F-fluorodeoxyglucose uptake in PET is associated with the tumor microenvironment in metastatic lymph nodes and prognosis in N2 lung adenocarcinoma.
    Nomura K; Nakai T; Nishina Y; Sakamoto N; Miyoshi T; Tane K; Samejima J; Aokage K; Kojima M; Sakashita S; Taki T; Miyazaki S; Watanabe R; Suzuki K; Tsuboi M; Ishii G
    Cancer Sci; 2022 Apr; 113(4):1488-1496. PubMed ID: 35023268
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic utility of metabolic parameters on FDG PET/CT for lymph node metastasis in patients with cN2 non-small cell lung cancer.
    Nakanishi K; Nakamura S; Sugiyama T; Kadomatsu Y; Ueno H; Goto M; Ozeki N; Fukui T; Iwano S; Chen-Yoshikawa TF
    BMC Cancer; 2021 Sep; 21(1):983. PubMed ID: 34474680
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic impact of the integration of volumetric quantification of the solid part of the tumor on 3DCT and FDG-PET imaging in clinical stage IA adenocarcinoma of the lung.
    Furumoto H; Shimada Y; Imai K; Maehara S; Maeda J; Hagiwara M; Okano T; Masuno R; Kakihana M; Kajiwara N; Ohira T; Ikeda N
    Lung Cancer; 2018 Jul; 121():91-96. PubMed ID: 29858033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.